Alcon Inc. (SWX:ALC)
84.40
-0.20 (-0.24%)
Mar 28, 2025, 5:31 PM CET
Alcon Revenue
In the year 2024, Alcon had annual revenue of $9.91B USD with 4.82% growth. Alcon had revenue of $2.50B in the quarter ending December 31, 2024, with 6.38% growth.
Revenue
$9.91B
Revenue Growth
+4.82%
P/S Ratio
4.66
Revenue / Employee
$387.16K
Employees
25,599
Market Cap
41.84B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.91B | 456.00M | 4.82% |
Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAlcon News
- 1 day ago - Alcon buys majority stake in Aurion Biotech - Seeking Alpha
- 2 days ago - Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease - Business Wire
- 2 days ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire
- 3 days ago - Alcon Stock Sees RS Rating Climb To 74 - Investor's Business Daily
- 3 days ago - Alcon upgraded at BofA Securities to Buy on earnings growth potential - Seeking Alpha
- 3 days ago - Alcon Inc (ALC) Launches Clareon Vivity IOL in Europe - GuruFocus
- 3 days ago - Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities - Business Wire
- 4 days ago - M&A Snapshot: Alcon to acquire LENSAR to boost its cataract equipment portfolio - Seeking Alpha